61 related articles for article (PubMed ID: 31682057)
1. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
Schluckebier D; Cousin VL; Petit LM; Belli D; Wildhaber B; Rougemont AL; Villard J; Ferrari-Lacraz S; McLin VA
Pediatr Transplant; 2020 Feb; 24(1):e13611. PubMed ID: 31682057
[TBL] [Abstract][Full Text] [Related]
2. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
4. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
Crespo M; Llinàs-Mallol L; Redondo-Pachón D; Butler C; Gimeno J; Pérez-Sáez MJ; Burballa C; Buxeda A; Arias-Cabrales C; Folgueiras M; Sanz-Ureña S; Valenzuela NM; Reed EF; Pascual J
Front Immunol; 2021; 12():703457. PubMed ID: 34305943
[TBL] [Abstract][Full Text] [Related]
5. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
Demir Z; Raynaud M; Aubert O; Debray D; Sebagh M; Duong Van Huyen JP; Del Bello A; Jolivet NC; Paradis V; Durand F; Muratot S; Lozach C; Chardot C; Francoz C; Kamar N; Sarnacki S; Coilly A; Samuel D; Vibert E; Féray C; Lefaucheur C; Loupy A
Am J Transplant; 2024 Jun; 24(6):954-966. PubMed ID: 38097016
[TBL] [Abstract][Full Text] [Related]
6. Including the liver in the visceral allograft: Impact on donor-specific anti-HLA antibodies and long-term outcomes.
Abele D; Gäbel M; Oltean M; Varkey J; Mölne J; Ekwall N; Borg H; Jacobsson H; Holgersson J; Herlenius G
Hum Immunol; 2024 Mar; 85(2):110767. PubMed ID: 38418315
[TBL] [Abstract][Full Text] [Related]
7. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
Das A; Rocque B; Remulla D; Raza M; Barbetta A; Bangerth S; Goldbeck C; Maw TT; Kim J; Kwon Y; Emamaullee J
Transplantation; 2023 May; 107(5):1115-1123. PubMed ID: 36398988
[TBL] [Abstract][Full Text] [Related]
8.
Beyzaei Z; Geramizadeh B; Bagheri Z; Karimzadeh S; Shojazadeh A
Front Immunol; 2020; 11():613128. PubMed ID: 33424868
[TBL] [Abstract][Full Text] [Related]
9. 25-hydroxyvitamin D sufficiency is associated with lower de novo anti-HLA donor specific antibody and better kidney transplant outcomes.
Bakis H; Bouthemy C; Corcuff JB; Lauro C; Guidicelli G; Cargou M; Guibet C; Taton B; Merville P; Couzi L; Moreau K; Visentin J
HLA; 2024 Jan; 103(1):e15187. PubMed ID: 37604171
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection.
Wiebe C; Rush DN; Gibson IW; Pochinco D; Birk PE; Goldberg A; Blydt-Hansen T; Karpinski M; Shaw J; Ho J; Nickerson PW
Am J Transplant; 2020 Sep; 20(9):2499-2508. PubMed ID: 32185878
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-6 predicts risk of kidney transplant failure independently of immunological risk.
Friedmann J; Schuster A; Reichelt-Wurm S; Banas B; Bergler T; Steines L
Transpl Immunol; 2024 Jun; 84():102043. PubMed ID: 38548029
[TBL] [Abstract][Full Text] [Related]
12. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.
Dumortier J; Conti F; Hiriart JB; Dharancy S; Duvoux C; Besch C; Houssel-Debry P; Latournerie M; Chermak F; Meszaros M; Pageaux GP; Radenne S; Boillot O; Hardwigsen J; Kounis I; Kamar N; Saliba F; Erard D; Del Bello A
Liver Transpl; 2023 Dec; 29(12):1313-1322. PubMed ID: 37367954
[TBL] [Abstract][Full Text] [Related]
13. T-cell infiltrate intensity is associated with delayed response to treatment in late acute cellular rejection in pediatric liver transplant recipients.
Peters AL; Rogers M; Begum G; Sun Q; Fei L; Leino D; Hildeman D; Woodle ES
Pediatr Transplant; 2023 May; 27(3):e14475. PubMed ID: 36691289
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1/PD-L1 mRNA expression in kidney transplant recipients.
Ekinci NS; Yilmaz VT; Kilinc Y; Kocak H; Darbas S; Kisaoglu A; Aydinli B; Uzuner SY; Ucar F
Clin Transplant; 2023 Nov; 37(11):e15104. PubMed ID: 37589946
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis.
Harmacek D; Weidmann L; Castrezana Lopez K; Schmid N; Korach R; Bortel N; von Moos S; Rho E; Helmchen B; Gaspert A; Schachtner T
Am J Transplant; 2024 Mar; ():. PubMed ID: 38548057
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serial monitoring of donor-specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients.
Klein K; Keck M; Langewisch E; Merani S; Hitchman K; Leick M
Pediatr Transplant; 2024 Feb; 28(1):e14638. PubMed ID: 37942670
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effect of COVID-19 on HLA-Antibody Profile in Renal Transplant Recipients.
Kljajic M; Sabljic Z; Juric I; Furic Cunko V; Zunec R; Burek Kamenaric M; Jelakovic B; Basic-Jukic N
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673655
[No Abstract] [Full Text] [Related]
18. Very Low Frequency of Pathological Findings in One-year Protocol Biopsies of Uneventful Standard Risk Kidney Transplant Recipients: Results From the Nordic Protocol Biopsy Study.
Helanterä I; Dörje C; Ortiz F; Varberg Reisæter A; Hammarström C; Lauronen J; Räisänen-Sokolowski A; Haugen AJ; Lempinen M; Åsberg A; Mjøen G
Transplant Direct; 2024 May; 10(5):e1621. PubMed ID: 38617466
[TBL] [Abstract][Full Text] [Related]
19. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study.
Agrawal A; Balakrishnan S; Gandhi MJ; Alexander MP; Cornell L; Bentall AJ; Kukla A; Stegall M; Schinstock CA
Transplantation; 2024 Apr; ():. PubMed ID: 38578704
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience.
Shizuku M; Kurata N; Jobara K; Fujimoto Y; Ogura Y
Ann Transplant; 2023 Dec; 28():e941456. PubMed ID: 38098225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
